所有图片(2)
About This Item
经验公式（希尔记法）:
C32H43NO4
CAS号:
分子量:
505.69
MDL號碼:
分類程式碼代碼:
12352205
PubChem物質ID:
NACRES:
NA.25
推荐产品
品質等級
化驗
≥98% (HPLC)
形狀
powder
應用
metabolomics
vitamins, nutraceuticals, and natural products
儲存溫度
−20°C
SMILES 字串
CC1(C)CC[C@]2(C(OC)=O)CC[C@@]([C@@]3([H])[C@]2([H])C1)(C)[C@]4(C)CC[C@@]5([H])C(C)(C)C(C(C#N)=C[C@]5(C)C4=CC3=O)=O
InChI
1S/C32H43NO4/c1-27(2)11-13-32(26(36)37-8)14-12-31(7)24(20(32)17-27)21(34)15-23-29(5)16-19(18-33)25(35)28(3,4)22(29)9-10-30(23,31)6/h15-16,20,22,24H,9-14,17H2,1-8H3/t20-,22-,24-,29-,30+,31+,32-/m0/s1
InChI 密鑰
WPTTVJLTNAWYAO-KPOXMGGZSA-N
基因資訊
human ... IKBKB(3551) , KEAP1(9817) , NFE2L2(4780) , PPARG(5468)
一般說明
CDDO-Me 是一种合成的三萜类化合物，具有抗炎、抗肿瘤和细胞保护作用。它来源于天然产物齐墩果酸。
應用
CDDO甲酯（甲基巴多索隆）已用于在肝脏缺血再灌注损伤(IRI)中检测其对肝细胞膜转运蛋白(HMT)的调控和对胆汁淤积症的缓解作用。它也作为NF E2相关因子2(NRF2)的激活剂，用于研究其防止黑色素瘤细胞死亡的作用。
生化／生理作用
CDDO-Me可抑制炎症介质，如白介素-6(IL-6)、IL-10和IL-12。它可增强TNF和化疗试剂诱导的细胞凋亡。CDDO-Me具有抗骨肉瘤细胞增殖活性，通过激活内源性线粒体依赖型细胞凋亡通路，可增强化疗试剂的有效性。它可作为进展型和致死型前列腺癌的辅助治疗手段。
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
其他客户在看
Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes.
Eitas T K, et al.
PLoS ONE, 12(9), e0184164-e0184164 (2017)
A synthetic triterpenoid, CDDO-Me, inhibits IKBα kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor KB?regulated gene products in human leukemic cells.
Shishodia S, et al.
Clinical Cancer Research, 12(6), 1828-1838 (2006)
The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection
Tran T A, et al.
Journal of Neuroinflammation, 5(1), 1-1 (2008)
Timothy K Eitas et al.
PloS one, 12(9), e0184164-e0184164 (2017-09-09)
Burn patients suffer from immunological dysfunction for which there are currently no successful interventions. Similar to previous observations, we find that burn shock patients (≥15% Total Burn Surface Area (TBSA) injury) have elevated levels of the innate immune cytokines Interleukin-6
Laure Maneix et al.
Cancers, 13(4) (2021-03-07)
Multiple myeloma and its precursor plasma cell dyscrasias affect 3% of the elderly population in the US. Proteasome inhibitors are an essential part of several standard drug combinations used to treat this incurable cancer. These drugs interfere with the main
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门